Biotech entity
pharma is the sole category represented across all 2 tracked stories. Dr. Ben Rome is most often covered alongside Eli Lilly, which appears in 2 of these 2 stories. We currently track 2 Biotech stories that mention Dr. Ben Rome, published between July 16, 2026 and July 19, 2026.
Last mentioned: Jul 19, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 2 tracked stories. Dr. Ben Rome is most often covered alongside Eli Lilly, which appears in 2 of these 2 stories. We currently track 2 Biotech stories that mention Dr. Ben Rome, published between July 16, 2026 and July 19, 2026. Each carries 9.5 original sources on average.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 6 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Dr. Ben Rome. Shared-story counts are live from our verified record — not editorial picks.
Biopharma companies cooperated just enough to avoid tariffs, placing only 92 products on TrumpRx while keeping high-margin cancer, HIV, and inflammation therapies off the discount menu—revealing industry’s strategic calculus.
TrumpRx, the Trump administration's drug discount website, has secured voluntary pricing deals on only 92 brand-name drugs—less than 12% of the 800-plus products from 17 major pharmaceutical companies. High-cost therapies for inflammatory diseases, HIV, and cancer are largely excluded, raising doubts about industry's willingness to compromise on pricing without legislation.
Dr. Ben Rome is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
